TuHURA Biosciences (HURA) has been added to the Russell 3000 Index, with automatic inclusion in the Russell 2000 Index, as a part of the 2025 Russell indexes annual reconstitution. The company’s addition to the Russell 3000 Index and the Russell 2000 Index was effective as of market close, Friday, June 27th. Over $10T in assets are benchmarked against Russell’s U.S. Indexes, which are part of FTSE Russell, a global index provider wholly owned by London Stock Exchange Group (LDNXF).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HURA:
- TuHURA Biosciences Completes Acquisition of Kineta, Inc.
- TuHURA Biosciences Increases Authorized Common Stock Shares
- Buy Rating for TuHURA Biosciences: Promising Phase 3 Study and Strategic Merger with Kineta Inc.
- TuHURA Biosciences initiates Phase 3 approval trial of IFx-2.0 in carcinoma
- TuHURA Biosciences Approves Merger and Share Increase